Table 1 Baseline characteristics of patients with PIVSR

Age, year

Male, %

70.7 (10.70)

38 (61.3)

68.4 (7.35)

11 (61.1)

71.61 (11.75)

27 (61.4)

0.199

1.000

BMI, kg/m²

Respiratory Rate

HR

SBP, mmHg

DBP, mmHg

Killip III/IV class, %

Hypertension, %

Hyperlipidemia, %

History of CAD, %

Current smoker, %

Current drinker, %

LVEF, %

LVEDD, mm

Hemoglobin, g/L

Log NT-pro BNP

CTn I, mmol/L

CK-MB, IU/L

LDH, IU /L

Serum glucose, mmol/L

Creatinine umol/L

WBC, 10⁶/L

TG, mmol/L

HDL, mmol/L

LDL, mmol/L

TC, mmol/L

22.42 (3.24)

20.0 (18.3–22.8)

95.5 (82.3-109.5)

101.5 (92.0-124.8)

70.3 (16.10)

47 (75.8)

27 (43.5)

16 (25.8)

10 (16.1)

15 (24.19)

13 (20.97)

56.0 (50.0–61.0)

50.68 (5.50)

123.72 (20.43)

3.16 (2.84–3.63)

1.74 (0.05–15.18)

3.82 (1.08–41.93)

742.20 (321.5-2001.5)

8.04 (6.30-10.51)

107.5 (79.15-148.72)

11.43 (7.95–16.36)

1.08 (0.86–1.55)

0.94 (0.74–1.26)

2.34 (1.81–3.13)

3.65 (3.29–4.65)

22.86 (3.55)

20.0 (18.3–20.0)

90.0 (82.0-101.5)

121.5 (98.0-126.5)

75.3 (10.11)

14 (77.8)

7 (39.0)

5 (27.8)

5 (27.8)

2 (11.11)

6 (33.33)

61.5 (56.8–65.0)

51.06 (5.48)

120.44 (22.47)

3.06 (2.73–3.17)

0.10 (0.05–2.09)

1.10 (1.00-3.82)

297.50 (226.80-498.33)

6.93 (5.00-8.34)

82.85 (72.92-111.23)

7.72 (6.31–9.20)

1.06 (0.95–1.49)

0.82 (0.73–0.94)

2.28 (1.81–2.74)

3.55 (3.11–4.22)

22.24 (3.13)

20.0 (18.8–24.3)

98.5 (82.8-112.8)

100.5 (90.0-119.0)

68.3 (17.67)

33 (75.0)

20 (45.5)

11 (25.0)

5 (11.4)

13 (29.55)

7 (15.91)

53.0 (48.9–60.0)

50.52 (5.56)

125.07 (19.65)

3.26 (2.95–3.83)

3.94 (0.28–19.68)

7.96 (1.35–52.23)

1159.90 (406.35-2479.45)

9.12 (7.07–12.42)

117.55 (83.02-181.65)

14.35 (10.03–18.24)

1.08 (0.74–1.54)

0.99 (0.79–1.37)

2.36 (1.83–3.15)

3.69 (3.29–4.86)

0.522

0.126

0.261

0.064

0.053

1.000

0.848

1.000

0.137

0.193

0.171

0.003

0.732

0.452

0.024

0.002

0.002

< 0.001

0.008

0.016

< 0.001

0.710

0.051

0.368

0.381